Pocong, Ritchel .
HRN: 14-94-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2024
CEFUROXIME 750MG (VIAL)
06/12/2024
06/19/2024
IV
646
Q8
Pneumonia, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes